Vanishing bile duct syndrome in Hodgkin's disease
case report
Keywords:
Hodgkin's disease, Vanishing bile duct syndrome, Liver failureAbstract
CONTEXT: Liver damage is relatively common in patients affected by Hodgkin's disease. A smaller proportion of cases develops jaundice. Recently, the vanishing bile duct syndrome was described in Hodgkin's disease. The mechanisms of this severe complication have been poorly understood until now. OBJECTIVE: To describe a rare case of intra-hepatic cholestasis due to vanishing bile duct syndrome. DESIGN: Case report. CASE REPORT: A 38-year-old male patient affected by Hodgkin's disease. Liver biopsy showed no detectable Hodgkin's disease. Intra-hepatic cholestasis was found and none of the six portal tracts analyzed contained normal bile ducts. The treatment was based on conventional and high-dose escalation chemotherapy. The patient died from an irreversible liver failure while in complete remission from Hodgkin's disease.
Downloads
References
Jaffe ES. Malignant Lymphoma: Pathology of hepatic involvement. Semin Liver Dis 1987;7:257-68.
Hubscher SG, Lumley AL, Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 1993;17(1):70-7.
Gottrand F, Cullu F, Mazingue F, et al. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease. J Ped Gastroenterol Nutr 1997;24:430-3.
Desmet VJ. Vanishing bile duct disorders. Prog Liver Dis 1992;10:89-121.
Burra P, Elias E. Vanishing bile duct syndrome. Br J Surg 1992;79:604-5.
Galperin C, Gershwin ME. Immunopathogenesis of gastrointestinal and hepatobiliary diseases. JAMA 1997;278(22):1946-55.
Klimo P, Connors JM. MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. J Clin Oncol 1985;3:1174-82.
Cervantes F, Briones J, Bruguera M, et al. Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. Ann Hematol 1996;72:357-60.
Forbes GM, Jeffrey GP, Shilkin KB, Reed WD. Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome. Gastroenterology 1992;102:1385-8.
Altraif I, Lilly L, Wanless IR, Heathcote J. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulphamethoxazole. Am J Gastroenterol 1994;89(8):1230-4.
Davies MH, Harrison RF, Elias E, Hubscher SG. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol 1994;20(1):112-6.
Hubscher SG, Buckels JAC, Elias E, et al. Reversible Vanishing Bile Duct Syndrome after Liver Transplantation: Report of 6 Cases. Transplant Proc 1991;23(1):1415-6.
